Skip to Main Content

BOSTON — Vertex Pharmaceuticals reshaped the way doctors treat cystic fibrosis, turning what was once a childhood death sentence into a manageable condition — and making the Boston biotech a multibillion-dollar company in the process.

Its next goal? Reproducing that success.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


Create a display name to comment

This name will appear with your comment